Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Psychiatry

Reduction of SERT binding in Ecstasy users: Reproducibility of PET studies

Melin Vranesic, Zsolt Szabo, Jozsef Varga, George Ricaurte and Una McCann
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 109P;
Melin Vranesic
1Radiology/Nuc Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zsolt Szabo
1Radiology/Nuc Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jozsef Varga
4Institute of Nuclear Medicine, University of Debrecen, Debrecen, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Ricaurte
2Neurology, Johns Hopkins, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Una McCann
3Psychiatry, Johns Hopkins, Baltimore, Maryland;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

368

Objectives: Carbon-11-labeled-McN-5652 and Carbon-11-labeled-DASB have both recently been highlighted as tracers which detect reduction of the serotonin transporter (SERT) in ecstasy users. This finding has been confirmed by different image processing techniques applied to identical datasets but not to different study populations. We tested the control-user differences of the binding parameters between tracers as well as studies for reproducibility. Methods: To test between-tracer reproducibility, PET studies were obtained with both MCN and DASB in 42 subjects (19 controls, 23 users). To test between-study reproducibility, PET studies with DASB obtained in the same 42 subjects were compared to PET studies obtained in a new set of 32 subjects (16 controls, 16 users). Using compartmental modeling the total tissue distribution volume (DV) was calculated. Correction for nonspecific binding was achieved both by subtracting the cerebellar DV from the regional DV (=DVspec) and by dividing regional DV by cerebellar DV (=DVR). Reduction of binding was calculated from the percent difference between controls and users. Reproducibility was tested by rank correlation, linear correlation, and by factor analysis. Results: Between tracer reproducibility (r) of DV, DVspec and DVR was 0.481, 0.910 and 0.522, respectively. The between study reproducibility (r) of the same three parameters was 0.786, 0.924, and 0.806. Factor analysis showed that 87% of variance can be ascribed to two factors. The reductions of DVspec for both comparisons and both tracers showed high loads on factor 1, while reductions of DVR showed high loads on factor 2. The factorial assignment of DV reductions was less consistent. Conclusions: The results indicate outstanding between-tracer as well as between-study reproducibility of DVspec and excellent between study reproducibility of DV and DVR. These results may assist design and interpretation of PET studies of the SERT in the future.

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reduction of SERT binding in Ecstasy users: Reproducibility of PET studies
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reduction of SERT binding in Ecstasy users: Reproducibility of PET studies
Melin Vranesic, Zsolt Szabo, Jozsef Varga, George Ricaurte, Una McCann
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 109P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reduction of SERT binding in Ecstasy users: Reproducibility of PET studies
Melin Vranesic, Zsolt Szabo, Jozsef Varga, George Ricaurte, Una McCann
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 109P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Psychiatry

  • Differences in dopamine release in Tourette's syndrome and obsessive-compulsive disorder
  • Effects of trigeminal nerve stimulation on regional brain activity in depression
  • Correlation of early-phase F-18 Florbetapir (AV-45) PET images to FDG images
Show more Neurosciences: Psychiatry

Psychiatry I

  • [I-123]Iomazenil SPECT imaging of GABA-A-benzodiazepine receptor in smokers and nonsmokers
  • In vivo PET of cerebral cannabinoid-1 receptor availability is inversely correlated to novelty seeking in healthy human volunteers
  • Nicotinic acetylcholine receptor availability in nonsmoker men and women
Show more Psychiatry I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire